Investment Analysts’ upgrades for Tuesday, May 26th:
Agilon Health (NYSE:AGL) was upgraded by analysts at Barclays PLC from an underweight rating to an equal weight rating. They currently have $81.00 price target on the stock.
Albemarle (NYSE:ALB) was upgraded by analysts at Vertical Research from a hold rating to a buy rating. They currently have $224.00 target price on the stock.
Astrana Health (NASDAQ:ASTH) was upgraded by analysts at Barclays PLC from an equal weight rating to an overweight rating. Barclays PLC currently has $50.00 target price on the stock.
Atmos Energy (NYSE:ATO) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.
BHP Group (LON:BHP) was upgraded by analysts at JPMorgan Chase & Co. to a neutral rating. The firm currently has GBX 3,400 target price on the stock, up from their previous target price of GBX 2,600.
Cognex (NASDAQ:CGNX) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. JPMorgan Chase & Co. currently has $75.00 price target on the stock, up from their previous price target of $65.00.
Energy Transfer (NYSE:ET) was upgraded by analysts at Jefferies Financial Group Inc. from a hold rating to a buy rating. Jefferies Financial Group Inc. currently has $23.00 target price on the stock.
Marvell Technology (NASDAQ:MRVL) was upgraded by analysts at HSBC Holdings plc from a hold rating to a buy rating. They currently have $300.00 target price on the stock.
ONEOK (NYSE:OKE) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.
Occidental Petroleum (NYSE:OXY) was upgraded by analysts at Barclays PLC from an equal weight rating to an overweight rating. The firm currently has $72.00 price target on the stock, up from their previous price target of $59.00.
Rio Tinto Group (LON:RIO) was upgraded by analysts at JPMorgan Chase & Co. to a neutral rating. The firm currently has GBX 8,280 target price on the stock, up from their previous target price of GBX 7,200.
Timken (NYSE:TKR) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. JPMorgan Chase & Co. currently has $150.00 price target on the stock, up from their previous price target of $130.00.
Travelers Companies (NYSE:TRV) was upgraded by analysts at JPMorgan Chase & Co. from an underweight rating to a neutral rating. They currently have $322.00 target price on the stock, up from their previous target price of $316.00.
Receive News & Ratings for Agilon Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.
